Bausch Health Companies Inc.
BHC
$6.68
$0.243.73%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.82% | 12.26% | 9.49% | 7.05% | 5.25% |
| Total Other Revenue | 3.85% | -25.00% | -9.68% | -14.29% | 8.33% |
| Total Revenue | 12.73% | 11.73% | 9.26% | 6.81% | 5.29% |
| Cost of Revenue | 1.05% | 5.28% | 9.77% | 7.76% | 6.26% |
| Gross Profit | 17.78% | 14.63% | 9.06% | 6.45% | 4.87% |
| SG&A Expenses | 1.45% | -0.23% | 8.24% | -6.47% | 7.45% |
| Depreciation & Amortization | -12.11% | -5.86% | -8.88% | -7.66% | -5.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.19% | 2.09% | 5.76% | -0.10% | 4.86% |
| Operating Income | 69.58% | 75.42% | 20.77% | 31.80% | 7.28% |
| Income Before Tax | 148.57% | -2,780.85% | -73.21% | 1,138.10% | 191.67% |
| Income Tax Expenses | 633.33% | 97.44% | 43.24% | -47.89% | -75.51% |
| Earnings from Continuing Operations | 103.13% | -1,563.95% | -205.10% | 296.74% | 12,900.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -110.00% | -71.43% | -80.00% | -128.57% | 81.82% |
| Net Income | 74.32% | -2,353.45% | -220.43% | 310.59% | 1,380.00% |
| EBIT | 69.58% | 75.42% | 20.77% | 31.80% | 7.28% |
| EBITDA | 38.22% | 35.55% | 11.84% | 18.13% | 2.69% |
| EPS Basic | 72.43% | -2,332.82% | -220.00% | 306.63% | 1,366.91% |
| Normalized Basic EPS | 5,264.41% | 589.62% | 27.73% | 40.57% | -92.33% |
| EPS Diluted | 70.43% | -2,332.82% | -221.46% | 306.63% | 1,366.91% |
| Normalized Diluted EPS | 5,265.81% | 589.62% | 27.73% | 40.57% | -92.35% |
| Average Basic Shares Outstanding | 1.11% | 0.87% | 0.36% | 1.93% | 0.82% |
| Average Diluted Shares Outstanding | 1.34% | 0.87% | 0.36% | 1.93% | 0.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |